Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Kinston › NPI 1962446385
Hospital

Lenoir Memorial Hospital, Incorporated

Lenoir Memorial Hospital, Incorporated was paid $27.15M by Medicaid between Jan 2018 and Dec 2024, across 169 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.

33Billing provider infoLENOIR MEMORIAL HOSPITAL, INCORPORATED
KINSTON, NC 28503
33aNPI1962446385assigned 06/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.15M
24GClaims525,634
24DCodes billed169
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#20 of 92
Median peer was paid$11.47M
This provider vs. median2.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201863,716$2.61M
201968,967$3.08M
202052,314$2.39M
202150,416$2.77M
202286,142$4.69M
202394,491$5.52M
2024incomplete109,588$6.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 48,955 45,558 $7.43M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 30,443 28,119 $6.25M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 11,086 10,308 $2.99M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 5.6% 9,901 9,044 $1.52M
70450 Computed tomography, head or brain; without contrast material 4.1% 5,057 4,703 $1.11M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.9% 13,891 13,054 $1.07M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 875 831 $810K
96361 Intravenous infusion, hydration; each additional hour 2.2% 7,846 6,792 $594K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.8% 11,037 10,231 $481K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 14,618 13,211 $369K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 5,568 4,916 $339K
71045 Radiologic examination, chest; single view 1.1% 9,920 9,240 $302K
157 more codes
80053 Comprehensive metabolic panel 1.0% 32,743 $277K
J3490 Unclassified drugs <1% 47,034 $243K
71046 Radiologic examination, chest; 2 views <1% 4,104 $241K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,703 $236K
74022 <1% 2,255 $234K
96375 Therapeutic injection; each additional sequential IV push <1% 6,298 $167K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 14,336 $156K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,324 $150K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 195 $149K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,244 $130K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,266 $111K
81025 <1% 13,656 $105K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,125 $95K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,782 $84K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,782 $84K
84484 <1% 10,882 $83K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 518 $79K
87428 <1% 985 $68K
81001 <1% 14,493 $51K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,558 $50K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,193 $48K
83880 <1% 2,063 $47K
81003 <1% 19,489 $45K
83690 <1% 6,683 $43K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,521 $42K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 649 $41K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 840 $41K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 614 $38K
80305 <1% 2,897 $37K
36415 Collection of venous blood by venipuncture <1% 17,272 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,546 $35K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 240 $32K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 491 $32K
85730 <1% 6,810 $30K
71275 Computed tomographic angiography, chest, with contrast material <1% 62 $26K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,162 $24K
77336 <1% 416 $22K
85610 <1% 7,404 $22K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,158 $17K
81513 <1% 818 $17K
87430 <1% 1,196 $16K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 14 $16K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 541 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,596 $13K
84443 Thyroid stimulating hormone (TSH) <1% 945 $13K
72125 Computed tomography, cervical spine; without contrast material <1% 38 $13K
83605 <1% 1,410 $11K
83735 <1% 2,008 $11K
82550 <1% 2,488 $11K
73610 <1% 90 $9K
74019 <1% 117 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 101 $9K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 25 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,333 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 277 $8K
87040 <1% 794 $8K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 91 $7K
87088 <1% 1,049 $7K
97597 <1% 468 $7K
87081 <1% 1,134 $7K
94761 <1% 544 $7K
85379 <1% 801 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 219 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,447 $6K
G0378 Hospital observation service, per hour <1% 195 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,271 $6K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 30 $6K
73130 <1% 58 $6K
73030 <1% 62 $6K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 106 $5K
A9270 Non-covered item or service <1% 24,255 $5K
82962 <1% 2,632 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 95 $5K
99213 Doctor's office visit, returning patient (routine) <1% 369 $5K
73562 <1% 38 $5K
95811 <1% 12 $5K
84702 <1% 392 $4K
86850 <1% 358 $4K
77300 <1% 31 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 196 $4K
86780 <1% 262 $4K
88304 <1% 36 $4K
J8597 Antiemetic drug, oral, not otherwise specified <1% 811 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 359 $4K
87420 <1% 270 $4K
17250 <1% 52 $4K
V2632 Posterior chamber intraocular lens <1% 471 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 13 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 61 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,968 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 351 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,039 $3K
73630 <1% 43 $3K
74018 <1% 33 $3K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 51 $2K
86803 <1% 138 $2K
87210 <1% 512 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 967 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 14 $2K
87077 <1% 260 $2K
82805 <1% 77 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 43 $2K
86901 <1% 545 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 447 $2K
86900 <1% 545 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 194 $2K
85027 <1% 297 $2K
80061 Lipid panel <1% 108 $1K
68841 <1% 152 $1K
J7510 Prednisolone oral, per 5 mg <1% 220 $1K
94060 <1% 18 $1K
86762 <1% 56 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 329 $1K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 200 $1K
86787 <1% 58 $975.44
82731 <1% 13 $952.66
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 22 $924.37
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 29 $922.42
82803 <1% 57 $841.79
J1096 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg <1% 160 $826.52
59025 Fetal non-stress test <1% 14 $775.26
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 397 $733.22
82948 <1% 189 $672.56
00142 <1% 247 $610.62
87186 <1% 74 $582.80
96376 <1% 27 $535.05
94729 <1% 17 $496.00
94726 <1% 17 $490.34
84100 <1% 129 $449.51
85660 <1% 61 $438.30
87340 <1% 38 $426.95
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 677 $420.55
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 193 $364.60
J2704 Injection, propofol, 10 mg <1% 190 $352.72
80143 <1% 45 $323.42
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 16 $315.69
90715 <1% 14 $289.59
J3010 Injection, fentanyl citrate, 0.1 mg <1% 114 $286.72
86885 <1% 50 $236.54
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 273 $213.98
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 43 $130.01
82570 <1% 16 $107.30
84439 <1% 12 $97.27
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 40 $83.78
84550 <1% 15 $82.40
84156 <1% 16 $76.04
82010 <1% 17 $75.30
C9113 Injection, pantoprazole sodium, per vial <1% 17 $53.75
80179 <1% 28 $42.11
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 26 $36.94
J2550 Injection, promethazine hcl, up to 50 mg <1% 29 $29.45
A6213 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing <1% 17 $29.42
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 17 $21.35
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 324 $13.47
J0173 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg 0% 49 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 46 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 225 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAYDEN, CRYSTAL (CEO)
Same official

Other billing entities under HAYDEN, CRYSTAL

Full network →
ProviderLocationPaid
Lenoir Memorial Hospital, IncorporatedKinston, NC$4.70M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.